What is HARMONY?

The HARMONY Alliance is a public-private European Network of Excellence, established in January 2017.

Our mission is to unlock and spread valuable knowledge on hematologic malignancies (blood cancers) among a large number of stakeholders, with the goal to harness and mine Big Data to speed up the development of improved treatments for patients and more effective treatment strategies.

We currently have 53 Partners and 27 Associated Membersfrom 22 countries, including 8 pharmaceutical companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA)

Work Package 2: Definition of Outcomes

WP2 is focused on defining the specific questions that are relevant to each hematological malignancy (HM). The coordination of the data that emerges will ensure that results will be generally applicable to patients with blood cancers. WP2 will define what outcomes need to be achieved in terms of each type of blood malignancy, including both clinical outcome measures and the description of which factors are relevant for both patients and caregivers.

All DelphiManager data is stored on a secure server in the University of Liverpool data centre. For more information please contact delphimg@liverpool.ac.uk